Compare Saraswati Griya Lestari Tbk. (HOTL) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Saraswati Griya Lestari Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Saraswati Griya Lestari Tbk. trades at Rp50 (market cap 177.5B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Saraswati Griya Lestari Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| HOTL | SCPI | |
|---|---|---|
Market Cap | 177.5B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Saraswati Griya Lestari Tbk.
Saraswati Griya Lestari, PT (the Company) was established based on Notarial Deed No. 5 dated March 23, 2006.
Read more on HOTL →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
